LYELL IMMUNOPHARMA INC

Historical 13F Holders

Symbol
LYEL
CUSIP
55083R203
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 55083R203 since 12/18/2024, largest first.

Filer % of Class Filed
ARCH Venture Fund IX, L.P. 13G/A
13.9% 5/15/2026
Event 3/31/2026
Innovative Cellular Therapeutics Holdings Ltd 13G/A 12.3% 6/18/2026
Event 5/18/2026
Euler Fund, L.P. 13G
6.7% 4/21/2026
Event 3/6/2026
Explore Investments LLC/DE 13G/A
6.6% 5/8/2026
Event 3/31/2026
Gates Frontier, LLC 13G
5.6% 8/1/2025
Event 7/25/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
MWG Caph Ltd 13G/A
4.3% 5/11/2026
Event 3/31/2026
NEWTON (PTC) Ltd 13G/A
3.9% 11/12/2025
Event 9/30/2025
Foresite Capital Fund IV, L.P. 13G/A
2.7% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 31 2.24 M $21.9M
2026 Q2 87 12.0 M $168M
2026 Q1 75 12.0 M $237M
2025 Q4 68 11.5 M $353M
2025 Q3 57 10.2 M $164M
2025 Q2 66 6.82 M $60.3M